Infectious Disease Diagnostics Market - Global Industry Analysis

Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments, and Software & Services), By Type of Testing (Laboratory Testing, and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies), By Disease Type (COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, and Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028

Published Date: 16-May-2022 Category: Medical Device Report Format : PDF Pages: 190 Report Code: ZMR-2145 Status : Published

The global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period.

Description

Industry Prospective:

The global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period. The report analyzes the digital remittance market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.

Infectious Disease Diagnostics Market: Overview

Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens, and molecular methods. Diagnostic tests are crucial for diagnosing diseases and for the overall improvement of global health. Traditional methods were time-consuming and often produced inaccurate results. This led to the emergence of quick, accurate, and portable testing products in the market.

The growth of the infectious disease diagnosis market is mainly due to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, Swine Flu, etc.; growing awareness for early detection using specific diagnostic tests; progress in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized testing services.

COVID-19 Impact:

The COVID-19 pandemic had a positive impact on the infectious disease diagnostics market owing to the use of infectious disease diagnostic methods for COVID-19 testing. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement. With covid 19, people have become more conscious of infectious diseases, and responding to them has become a pressing medical issue globally. The COVID-19 pandemic has overall, stressed the healthcare systems in the world and amplified the need for the development of diagnostic instruments & diagnostic service centers. An increase in the number of COVID-19 cases coursed the demand for real-time polymerase chain reaction (RT-PCR) tests to detect COVID-19.

Global Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market: Growth Drivers

The global prevalence of infectious diseases and onset of COVID-19

The prevalence of infectious diseases in developed and developing regions positively influenced the growth of the infectious disease diagnostics market and is expected to be a major factor in its growth during the forecast period. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for the infectious disease diagnostics market.

Infectious Disease Diagnostics Market: Restraints

Lack of accuracy of point of care diagnostic tests and Unfavorable reimbursement scenario

In underdeveloped and low-income regions, lack of training among clinicians and poor accessibility has led to decreased adoption of Infectious Disease Diagnostics test kits. Moreover, Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.

Infectious Disease Diagnostics Market: Segmentation

The global infectious disease diagnostics market is segregated based on product, type of testing, technology, disease type, and end-user.

By product, the global market is distinguished into Reagents, Kits, and Consumables, Instruments, and Software & Services. In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market. The driving factor for the growth of this segment was the frequent purchase of these products due to their recurrent usage.

By technology, the global market is bifurcated into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies. The immunodiagnostics segment is projected to account for the largest share. This can be attributed to the increasing use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Recent Developments

  • In May 2021, Torus Biosystems revealed the USD 25 million series-A financing to advance infectious disease diagnostics across healthcare settings.
  • In March 2020, Abbott Laboratories launched the ID NOW COVID-19 Test.

Regional Landscape

The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices. However, Asia-Pacific is expected to register the highest CAGR from 2021 to 2028, owing to an increase in the prevalence of infectious diseases, a rise in demand for early diagnosis, development of healthcare infrastructure, technological advancement in diagnostic testing, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Competitive Landscape

Some of the main competitors dominating the global infectious disease diagnostics market include - Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).

Global infectious disease diagnostics market is segmented as follows:

By Product

  • Reagents, Kits, and Consumables
  • Instruments
  • Software & Services

By Type of Testing

  • Laboratory Testing
  • POC Testing

By Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • PCR
  • INAAT
  • DNA Sequencing & NGS
  • DNA Microarrays
  • Other technologies

By Disease Type

  • COVID-19
  • HIV
  • HAIs
  • Hepatitis
  • CT/NG
  • HPV
  • TB
  • Influenza
  • Other Infectious Diseases

By End-User

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Research Institutes
  • Other End Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Infectious Disease Diagnostics Market, (2022 - 2028) (USD Million)
    • 2.2 Global Infectious Disease Diagnostics Market : snapshot
  • Chapter 3. Global Infectious Disease Diagnostics Market - Industry Analysis
    • 3.1 Infectious Disease Diagnostics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 The global prevalence of infectious diseases and onset of COVID-19
    • 3.3 Market Restraints
      • 3.3.1. Lack of accuracy of point of care diagnostic tests and Unfavorable reimbursement scenario
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By Type of Testing
      • 3.7.3 Market attractiveness analysis By Technology
      • 3.7.4 Market attractiveness analysis By Disease Type
      • 3.7.5 Market attractiveness analysis By End-User
  • Chapter 4. Global Infectious Disease Diagnostics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Infectious Disease Diagnostics Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Infectious Disease Diagnostics Market - Product Analysis
    • 5.1 Global Infectious Disease Diagnostics Market overview: By Product
      • 5.1.1 Global Infectious Disease Diagnostics Market share, By Product, 2021 and 2028
    • 5.2 Reagents, Kits, and Consumables
      • 5.2.1 Global Infectious Disease Diagnostics Market by Reagents, Kits, and Consumables, 2022 - 2028 (USD Million)
    • 5.3 Instruments
      • 5.3.1 Global Infectious Disease Diagnostics Market by Instruments, 2022 - 2028 (USD Million)
    • 5.4 Software & Services
      • 5.4.1 Global Infectious Disease Diagnostics Market by Software & Services, 2022 - 2028 (USD Million)
  • Chapter 6. Global Infectious Disease Diagnostics Market - Type of Testing Analysis
    • 6.1 Global Infectious Disease Diagnostics Market overview: By Type of Testing
      • 6.1.1 Global Infectious Disease Diagnostics Market share, By Type of Testing, 2021 and 2028
    • 6.2 Laboratory Testing
      • 6.2.1 Global Infectious Disease Diagnostics Market by Laboratory Testing, 2022 - 2028 (USD Million)
    • 6.3 POC Testing
      • 6.3.1 Global Infectious Disease Diagnostics Market by POC Testing, 2022 - 2028 (USD Million)
  • Chapter 7. Global Infectious Disease Diagnostics Market - Technology Analysis
    • 7.1 Global Infectious Disease Diagnostics Market overview: By Technology
      • 7.1.1 Global Infectious Disease Diagnostics Market share, By Technology, 2021 and 2028
    • 7.2 Immunodiagnostics
      • 7.2.1 Global Infectious Disease Diagnostics Market by Immunodiagnostics, 2022 - 2028 (USD Million)
    • 7.3 Clinical Microbiology
      • 7.3.1 Global Infectious Disease Diagnostics Market by Clinical Microbiology, 2022 - 2028 (USD Million)
    • 7.4 PCR
      • 7.4.1 Global Infectious Disease Diagnostics Market by PCR, 2022 - 2028 (USD Million)
    • 7.5 INAAT
      • 7.5.1 Global Infectious Disease Diagnostics Market by INAAT, 2022 - 2028 (USD Million)
    • 7.6 DNA Sequencing & NGS
      • 7.6.1 Global Infectious Disease Diagnostics Market by DNA Sequencing & NGS, 2022 - 2028 (USD Million)
    • 7.7 DNA Microarrays
      • 7.7.1 Global Infectious Disease Diagnostics Market by DNA Microarrays, 2022 - 2028 (USD Million)
    • 7.8 Other technologies
      • 7.8.1 Global Infectious Disease Diagnostics Market by Other technologies, 2022 - 2028 (USD Million)
  • Chapter 8. Global Infectious Disease Diagnostics Market - Disease Type Analysis
    • 8.1 Global Infectious Disease Diagnostics Market overview: By Disease Type
      • 8.1.1 Global Infectious Disease Diagnostics Market share, By Disease Type, 2021 and 2028
    • 8.2 COVID-19
      • 8.2.1 Global Infectious Disease Diagnostics Market by COVID-19, 2022 - 2028 (USD Million)
    • 8.3 HIV
      • 8.3.1 Global Infectious Disease Diagnostics Market by HIV, 2022 - 2028 (USD Million)
    • 8.4 HAIs
      • 8.4.1 Global Infectious Disease Diagnostics Market by HAIs, 2022 - 2028 (USD Million)
    • 8.5 Hepatitis
      • 8.5.1 Global Infectious Disease Diagnostics Market by Hepatitis, 2022 - 2028 (USD Million)
    • 8.6 CT/NG
      • 8.6.1 Global Infectious Disease Diagnostics Market by CT/NG, 2022 - 2028 (USD Million)
    • 8.7 HPV
      • 8.7.1 Global Infectious Disease Diagnostics Market by HPV, 2022 - 2028 (USD Million)
    • 8.8 TB
      • 8.8.1 Global Infectious Disease Diagnostics Market by TB, 2022 - 2028 (USD Million)
    • 8.9 Influenza
      • 8.9.1 Global Infectious Disease Diagnostics Market by Influenza, 2022 - 2028 (USD Million)
    • 8.10 Other Infectious Diseases
      • 8.10.1 Global Infectious Disease Diagnostics Market by Other Infectious Diseases, 2022 - 2028 (USD Million)
  • Chapter 9. Global Infectious Disease Diagnostics Market - End-User Analysis
    • 9.1 Global Infectious Disease Diagnostics Market overview: By End-User
      • 9.1.1 Global Infectious Disease Diagnostics Market share, By End-User, 2021 and 2028
    • 9.2 Diagnostic Laboratories
      • 9.2.1 Global Infectious Disease Diagnostics Market by Diagnostic Laboratories, 2022 - 2028 (USD Million)
    • 9.3 Hospitals & Clinics
      • 9.3.1 Global Infectious Disease Diagnostics Market by Hospitals & Clinics, 2022 - 2028 (USD Million)
    • 9.4 Academic Research Institutes
      • 9.4.1 Global Infectious Disease Diagnostics Market by Academic Research Institutes, 2022 - 2028 (USD Million)
    • 9.5 Other End Users
      • 9.5.1 Global Infectious Disease Diagnostics Market by Other End Users, 2022 - 2028 (USD Million)
  • Chapter 10. Infectious Disease Diagnostics Market - Regional Analysis
    • 10.1 Global Infectious Disease Diagnostics Market Regional Overview
    • 10.2 Global Infectious Disease Diagnostics Market Share, by Region, 2021 & 2028 (USD Million)
    • 10.3. North America
      • 10.3.1 North America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.3.1.1 North America Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 North America Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 North America Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 North America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 North America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 North America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 North America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 North America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 North America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 North America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 North America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.4. Europe
      • 10.4.2 Europe Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.4.2.1 Europe Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Europe Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 Europe Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Europe Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 Europe Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 Europe Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 Europe Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 Europe Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 Europe Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 Europe Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 Europe Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.5. Asia Pacific
      • 10.5.3 Asia Pacific Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.5.3.1 Asia Pacific Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Asia Pacific Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 Asia Pacific Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Asia Pacific Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 Asia Pacific Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 Asia Pacific Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 Asia Pacific Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 Asia Pacific Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 Asia Pacific Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.6. Latin America
      • 10.6.4 Latin America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.6.4.1 Latin America Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Latin America Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 Latin America Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Latin America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 Latin America Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 Latin America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 Latin America Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 Latin America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 Latin America Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 Latin America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 Latin America Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
    • 10.7. The Middle-East and Africa
      • 10.7.5 The Middle-East and Africa Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
        • 10.7.5.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 The Middle-East and Africa Infectious Disease Diagnostics Market, by Product, 2022 - 2028
      • 10.4.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 The Middle-East and Africa Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028
      • 10.5.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Type of Testing, 2022 - 2028 (USD Million)
    • 10.6 The Middle-East and Africa Infectious Disease Diagnostics Market, by Technology, 2022 - 2028
      • 10.6.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Technology, 2022 - 2028 (USD Million)
    • 10.7 The Middle-East and Africa Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028
      • 10.7.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by Disease Type, 2022 - 2028 (USD Million)
    • 10.8 The Middle-East and Africa Infectious Disease Diagnostics Market, by End-User, 2022 - 2028
      • 10.8.1 The Middle-East and Africa Infectious Disease Diagnostics Market, by End-User, 2022 - 2028 (USD Million)
  • Chapter 11. Company Profiles
    • 11.1 Abbott Laboratories (US)
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 F. Hoffmann-La Roche Ltd(Switzerland)
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 bioMérieux SA (France)
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Thermo Fisher Scientific Inc. (US)
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 Danaher Corporation (US)
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 Quidel Corporation(US)
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 Hologic Inc. (US)
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 Siemens Healthineers AG (Germany)
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 Becton
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 Dickinson and Company (US)
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments
    • 11.11 PerkinElmer Inc. (US)
      • 11.11.1 Overview
      • 11.11.2 Financials
      • 11.11.3 Product Portfolio
      • 11.11.4 Business Strategy
      • 11.11.5 Recent Developments
    • 11.12 QIAGEN (Netherlands)
      • 11.12.1 Overview
      • 11.12.2 Financials
      • 11.12.3 Product Portfolio
      • 11.12.4 Business Strategy
      • 11.12.5 Recent Developments
    • 11.13 Grifols S.A. (Spain)
      • 11.13.1 Overview
      • 11.13.2 Financials
      • 11.13.3 Product Portfolio
      • 11.13.4 Business Strategy
      • 11.13.5 Recent Developments
    • 11.14 DiaSorin S.p.A (Italy)
      • 11.14.1 Overview
      • 11.14.2 Financials
      • 11.14.3 Product Portfolio
      • 11.14.4 Business Strategy
      • 11.14.5 Recent Developments
    • 11.15 Bio-Rad Laboratories Inc. (US)
      • 11.15.1 Overview
      • 11.15.2 Financials
      • 11.15.3 Product Portfolio
      • 11.15.4 Business Strategy
      • 11.15.5 Recent Developments
    • 11.16 Sysmex Corporation (Japan)
      • 11.16.1 Overview
      • 11.16.2 Financials
      • 11.16.3 Product Portfolio
      • 11.16.4 Business Strategy
      • 11.16.5 Recent Developments
    • 11.17 Ortho Clinical Diagnostics (US)
      • 11.17.1 Overview
      • 11.17.2 Financials
      • 11.17.3 Product Portfolio
      • 11.17.4 Business Strategy
      • 11.17.5 Recent Developments
    • 11.18 Luminex Corporation (US)
      • 11.18.1 Overview
      • 11.18.2 Financials
      • 11.18.3 Product Portfolio
      • 11.18.4 Business Strategy
      • 11.18.5 Recent Developments
    • 11.19 Meridian Bioscience (US)
      • 11.19.1 Overview
      • 11.19.2 Financials
      • 11.19.3 Product Portfolio
      • 11.19.4 Business Strategy
      • 11.19.5 Recent Developments
    • 11.20 Genetic Signatures (Australia)
      • 11.20.1 Overview
      • 11.20.2 Financials
      • 11.20.3 Product Portfolio
      • 11.20.4 Business Strategy
      • 11.20.5 Recent Developments
    • 11.21 OraSure Technologies (US)
      • 11.21.1 Overview
      • 11.21.2 Financials
      • 11.21.3 Product Portfolio
      • 11.21.4 Business Strategy
      • 11.21.5 Recent Developments
    • 11.22 Trinity Biotech Plc. (Ireland)
      • 11.22.1 Overview
      • 11.22.2 Financials
      • 11.22.3 Product Portfolio
      • 11.22.4 Business Strategy
      • 11.22.5 Recent Developments
    • 11.23 Chembio Diagnostic Systems Inc. (US)
      • 11.23.1 Overview
      • 11.23.2 Financials
      • 11.23.3 Product Portfolio
      • 11.23.4 Business Strategy
      • 11.23.5 Recent Developments
    • 11.24 Seegene Inc. (South Korea)
      • 11.24.1 Overview
      • 11.24.2 Financials
      • 11.24.3 Product Portfolio
      • 11.24.4 Business Strategy
      • 11.24.5 Recent Developments
    • 11.25 Co-Diagnostics Inc. (US)
      • 11.25.1 Overview
      • 11.25.2 Financials
      • 11.25.3 Product Portfolio
      • 11.25.4 Business Strategy
      • 11.25.5 Recent Developments
    • 11.26 ELITechGroup (France)
      • 11.26.1 Overview
      • 11.26.2 Financials
      • 11.26.3 Product Portfolio
      • 11.26.4 Business Strategy
      • 11.26.5 Recent Developments
    • 11.27 Epitope Diagnostics Inc. (US)
      • 11.27.1 Overview
      • 11.27.2 Financials
      • 11.27.3 Product Portfolio
      • 11.27.4 Business Strategy
      • 11.27.5 Recent Developments
    • 11.28 Trivitron Healthcare (India)
      • 11.28.1 Overview
      • 11.28.2 Financials
      • 11.28.3 Product Portfolio
      • 11.28.4 Business Strategy
      • 11.28.5 Recent Developments
    • 11.29 Meril Life Sciences Pvt. Ltd. (India)
      • 11.29.1 Overview
      • 11.29.2 Financials
      • 11.29.3 Product Portfolio
      • 11.29.4 Business Strategy
      • 11.29.5 Recent Developments
    • 11.30 InBios International Inc. (US)
      • 11.30.1 Overview
      • 11.30.2 Financials
      • 11.30.3 Product Portfolio
      • 11.30.4 Business Strategy
      • 11.30.5 Recent Developments
    • 11.31 ABACUS Diagnostica Oy (Finland).
      • 11.31.1 Overview
      • 11.31.2 Financials
      • 11.31.3 Product Portfolio
      • 11.31.4 Business Strategy
      • 11.31.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Infectious Disease Diagnostics Market attractiveness, By Product
  • 6. Global Infectious Disease Diagnostics Market attractiveness, By Type of Testing
  • 7. Global Infectious Disease Diagnostics Market attractiveness, By Technology
  • 8. Global Infectious Disease Diagnostics Market attractiveness, By Disease Type
  • 9. Global Infectious Disease Diagnostics Market attractiveness, By End-User
  • 10. Global Infectious Disease Diagnostics Market share by Product, 2022 and 2028 (USD Million)
  • 11. Global Infectious Disease Diagnostics Market by Reagents, Kits, and Consumables, 2022 - 2028 (USD Million)
  • 12. Global Infectious Disease Diagnostics Market by Instruments, 2022 - 2028 (USD Million)
  • 13. Global Infectious Disease Diagnostics Market by Software & Services, 2022 - 2028 (USD Million)
  • 14. Global Infectious Disease Diagnostics Market share by Type of Testing, 2022 and 2028 (USD Million)
  • 15. Global Infectious Disease Diagnostics Market by Laboratory Testing, 2022 - 2028 (USD Million)
  • 16. Global Infectious Disease Diagnostics Market by POC Testing, 2022 - 2028 (USD Million)
  • 17. Global Infectious Disease Diagnostics Market share by Technology, 2022 and 2028 (USD Million)
  • 18. Global Infectious Disease Diagnostics Market by Immunodiagnostics, 2022 - 2028 (USD Million)
  • 19. Global Infectious Disease Diagnostics Market by Clinical Microbiology, 2022 - 2028 (USD Million)
  • 20. Global Infectious Disease Diagnostics Market by PCR, 2022 - 2028 (USD Million)
  • 21. Global Infectious Disease Diagnostics Market by INAAT, 2022 - 2028 (USD Million)
  • 22. Global Infectious Disease Diagnostics Market by DNA Sequencing & NGS, 2022 - 2028 (USD Million)
  • 23. Global Infectious Disease Diagnostics Market by DNA Microarrays, 2022 - 2028 (USD Million)
  • 24. Global Infectious Disease Diagnostics Market by Other technologies, 2022 - 2028 (USD Million)
  • 25. Global Infectious Disease Diagnostics Market share by Disease Type, 2022 and 2028 (USD Million)
  • 26. Global Infectious Disease Diagnostics Market by COVID-19, 2022 - 2028 (USD Million)
  • 27. Global Infectious Disease Diagnostics Market by HIV, 2022 - 2028 (USD Million)
  • 28. Global Infectious Disease Diagnostics Market by HAIs, 2022 - 2028 (USD Million)
  • 29. Global Infectious Disease Diagnostics Market by Hepatitis, 2022 - 2028 (USD Million)
  • 30. Global Infectious Disease Diagnostics Market by CT/NG, 2022 - 2028 (USD Million)
  • 31. Global Infectious Disease Diagnostics Market by HPV, 2022 - 2028 (USD Million)
  • 32. Global Infectious Disease Diagnostics Market by TB, 2022 - 2028 (USD Million)
  • 33. Global Infectious Disease Diagnostics Market by Influenza, 2022 - 2028 (USD Million)
  • 34. Global Infectious Disease Diagnostics Market by Other Infectious Diseases, 2022 - 2028 (USD Million)
  • 35. Global Infectious Disease Diagnostics Market share by End-User, 2022 and 2028 (USD Million)
  • 36. Global Infectious Disease Diagnostics Market by Diagnostic Laboratories, 2022 - 2028 (USD Million)
  • 37. Global Infectious Disease Diagnostics Market by Hospitals & Clinics, 2022 - 2028 (USD Million)
  • 38. Global Infectious Disease Diagnostics Market by Academic Research Institutes, 2022 - 2028 (USD Million)
  • 39. Global Infectious Disease Diagnostics Market by Other End Users, 2022 - 2028 (USD Million)
  • 40. Global Infectious Disease Diagnostics Market share, by Region, 2022 and 2028
  • 41. North America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 42. Europe Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 43. Asia Pacific Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 44. Latin America Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)
  • 45. The Middle-East and Africa Infectious Disease Diagnostics Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Infectious Disease Diagnostics Market: Snapshot
  • 2. Drivers of the Infectious Disease Diagnostics Market: impact analysis
  • 3. North America Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 4. North America Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 5. North America Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 6. North America Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 7. North America Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 8. U.S. Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 9. U.S. Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 10. U.S. Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 11. U.S. Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 12. U.S. Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 13. Canada Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 14. Canada Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 15. Canada Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 16. Canada Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 17. Canada Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 18. Europe Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 19. Europe Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 20. Europe Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 21. Europe Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 22. Europe Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 23. Germany Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 24. Germany Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 25. Germany Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 26. Germany Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 27. Germany Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 28. France Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 29. France Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 30. France Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 31. France Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 32. France Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 33. U.K. Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 34. U.K. Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 35. U.K. Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 36. U.K. Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 37. U.K. Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 38. Italy Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 39. Italy Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 40. Italy Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 41. Italy Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 42. Italy Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 43. Spain Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 44. Spain Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 45. Spain Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 46. Spain Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 47. Spain Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 48. Rest of Europe Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 49. Rest of Europe Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 50. Rest of Europe Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 51. Rest of Europe Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 52. Rest of Europe Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 53. Asia Pacific Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 54. Asia Pacific Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 55. Asia Pacific Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 56. Asia Pacific Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 57. Asia Pacific Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 58. China Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 59. China Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 60. China Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 61. China Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 62. China Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 63. Japan Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 64. Japan Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 65. Japan Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 66. Japan Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 67. Japan Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 68. India Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 69. India Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 70. India Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 71. India Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 72. India Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 73. South Korea Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 74. South Korea Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 75. South Korea Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 76. South Korea Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 77. South Korea Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 78. South-East Asia Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 79. South-East Asia Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 80. South-East Asia Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 81. South-East Asia Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 82. South-East Asia Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 83. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 84. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 85. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 86. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 87. Rest of Asia Pacific Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 88. Latin America Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 89. Latin America Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 90. Latin America Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 91. Latin America Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 92. Latin America Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 93. Brazil Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 94. Brazil Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 95. Brazil Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 96. Brazil Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 97. Brazil Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 98. Mexico Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 99. Mexico Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 100. Mexico Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 101. Mexico Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 102. Mexico Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 103. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 104. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 105. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 106. Rest of Latin America Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 107. Rest of Latin America Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 108. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 109. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 110. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 111. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 112. The Middle-East and Africa Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 113. GCC Countries Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 114. GCC Countries Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 115. GCC Countries Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 116. GCC Countries Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 117. GCC Countries Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 118. South Africa Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 119. South Africa Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 120. South Africa Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 121. South Africa Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 122. South Africa Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)
  • 123. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 124. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Type of Testing, 2022 - 2028 (USD Million)
  • 125. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Technology, 2022 - 2028 (USD Million)
  • 126. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By Disease Type, 2022 - 2028 (USD Million)
  • 127. Rest of Middle-East Africa Infectious Disease Diagnostics Market revenue, By End-User, 2022 - 2028 (USD Million)

Methodology

Free Analysis

Infectious disease is a type of disease caused by different microorganisms present in the surroundings. Infectious disease diagnostics includes different techniques, instruments, and consumables to diagnose the presence of microorganisms in the human body. The lack of sanitation and unhygienic conditions in the developing and under developing regions are the main causes for the increased prevalence of infectious disease. Due to the constant increase in the infectious diseases, most of the companies anticipate focusing on the development of in vitro diagnostics in the forecast period. Most of the infections are spread from bacteria and viruses. Bacterial infections and sexually transmitted diseases are the most common infections among others.

One of the major factors driving the growth of infectious disease diagnostics market over the forecast period is the increased prevalence of infectious disease. As per the UNAIDS report, there were around 36.7 million people in the world diagnosed with HIV/AIDS at the end of 2016 out of these, 2.1 million were children below 15 years of age. Increasing rate of infectious diseases has led to the increased adoption of molecular diagnostics over the forecast period. Moreover, increase in the government initiatives to prevent infectious disease and awareness programs are expected to promote the growth of infectious disease diagnostics market. Furthermore, market players are involved in the development of new and advanced technologies for the diagnosis of various infectious diseases at an early stage to provide better treatment. All the above factors are expected to support the growth of infectious disease diagnostics market over the forecast period. However, lack of awareness about advanced technologies and poor laboratory conditions are the major factors expected to inhibit the growth of infectious disease diagnostics market in the near future.

Infectious-Disease-Diagnostics-market.png

Infectious disease diagnostics market is segmented into product type, test type, application, and end-user. Based on product type, infectious disease diagnostics market is fragmented to consumables, instruments, and software & services. On the basis of test type, infectious disease diagnostics market is segmented into laboratory tests, an imaging test, and biopsies. Based on applications, infectious disease diagnostics market is classified into viral infection, bacterial infection, CNS infections, cardiovascular infection, GI infections, sexually transmitted disease, fungal infection, and others. Based on end users, infectious disease diagnostics market is segmented into diagnostic laboratories, contract research organization, academic and medical institutes, hospitals and surgical centers, ambulatory clinics, and home healthcare.

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are the key regions of infectious disease diagnostics market. North America is expected to dominate the market in the forecast period which is closely followed by Europe in the near future. The Asia Pacific is the fastest growing region over the forecast period owing to the presence of developing economies. Latin America and the Middle East & Africa are expected to witness a considerable growth rate.

Some of the major players of infectious disease diagnostics market include Becton Dickinson & Company, Affymetrix, Abbott Laboratories, Cepheid Inc., BioMerieux, Hologic Inc., DiaSorin, Bio-Rad Laboratories Inc., Alere Inc., and Danaher Corporation, among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The prevalence of infectious diseases in developed and developing regions positively influenced the growth of the infectious disease diagnostics market and is expected to be a major factor in its growth during the forecast period. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for the infectious disease diagnostics market.

According to the Market Research report, the global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period.

The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices. However, Asia-Pacific is expected to register the highest CAGR from 2021 to 2028.

Some of the main competitors dominating the global infectious disease diagnostics market include - Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed